Cite
HARVARD Citation
Foeldvari, I. et al. (n.d.). THU0511 Tocilizumab is a promising treatment option for therapy resistent juvenile localised scleroderma patients. Annals of the rheumatic diseases. pp. 399-400. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Foeldvari, I. et al. (n.d.). THU0511 Tocilizumab is a promising treatment option for therapy resistent juvenile localised scleroderma patients. Annals of the rheumatic diseases. pp. 399-400. [Online].